| Financial Year |
March 31 2023 |
| Monetary Funds |
746,322,221.68 |
| Held-for-trading Financial Assets |
131,371,914.45 |
| Notes Receivable |
27,706,083.01 |
| Accounts Receivable |
1,499,042,005.42 |
| Advances to Suppliers |
29,421,601.76 |
| Other Receivables |
58,032,076.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,195,405,862.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,137,500.00 |
| Other Current Assets |
62,628,077.00 |
| Total Current Assets |
4,013,674,121.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,165,486.24 |
| Long-term Equity Investment |
249,272,404.01 |
| Investment Properties |
-- |
| Fixed Assetes |
1,142,788,842.54 |
| Under-construction Projects |
114,951,753.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,320,204.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,830,895.90 |
| Deferred Income Tax Assets |
129,176,817.15 |
| Other Non-Current Assets |
114,961,621.82 |
| Sub-Total of Non-Current Assets |
1,914,988,394.36 |
| Total Assets |
5,928,662,515.89 |
| Short-Term Loans |
14,994,375.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
804,321,862.53 |
| Accounts Payable |
699,609,604.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,832,332.40 |
| Taxes Payable |
33,973,080.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,957,870.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,234,288.67 |
| Other Current Liabilities |
14,471,311.22 |
| Sub-Total of Current Liabilities |
1,772,748,676.73 |
| Long-term Loans |
536,731,778.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,200,494.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
47,948,281.24 |
| Deferred Income Tax Liabilities |
6,172,978.61 |
| Other Non-Current Liabilities |
6,811,997.34 |
| Sub-Total of Non-Current Liabilities |
636,171,834.34 |
| Total Liabilities |
2,408,920,511.07 |
| Paid-In Capital(Or Share Stock) |
442,946,457.00 |
| Capital Surplus |
1,163,157,491.10 |
| Surplus Reserve |
177,472,452.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,731,131,142.04 |
| Minority Stockholder's Interest |
4,385,696.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,515,356,308.07 |
| Owner's Equity（Stockholder's Equity） |
3,519,742,004.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,928,662,515.89 |
